FDA Inspection
Tanvex BioPharma USA, IncTanvex BioPharma USA, Inc – FDA Inspection, May 2, 2019
Record Details
This FDA Inspection record concerns Tanvex BioPharma USA, Inc, with an inspection on May 2, 2019, issued by the Los Angeles District Office, covering human drugs.
- People
- Amanda L. Fyles (Company Rep)
- Diane L. Raccasi (Issuing Officer)
- Frances Namuswe (Issuing Officer)
- Lindsey J. Brown (Issuing Officer)
- Thuy T. Nguyen (FDA Associated Person)
View Company Profile
ID · c5b7b252-bbc1-4931-a920-68fb24006170
Inspection Facts
- Inspection number
- 1095764
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Tanvex BioPharma USA, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2023 | Not classified | Los Angeles District Office |
Other documents for Tanvex BioPharma USA, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.